iHealthScreen’s Artificial Intelligence tool helps to diagnose AMD (Age-related Macular Degeneration) and can help prevent blindness.
Age-related Macular Degeneration is caused without any early signs or symptoms of adults. Early detection of AMD can help in prevention measures in time and able to stop it. The disease will weaken the light-sensitive layer of tissue known as the retina, it is located at the back of the eye and this is a leading cause of blindness. As to the U.S reports up to 24,000 cases are recorded each year.
The cases of AMD in the U.S are expected to grow in the next year from 2.1M to 5.4M. Therefore there is a need for large-scale screening and identification of individuals who are at chance of developing late Age-related Macular Degeneration.
Routine screening is required for managing diabetic retinopathy. People with diabetes when visiting their general practitioner they are mentioned to an ophthalmologist. The ophthalmologist checks the patient’s eyes for any signs of diabetic retinopathy. Due to the shortage of ophthalmologists, about half of people with diabetes did not get their eyes examined every year.
Since these specialists require great training and particular equipment as well as their scarcity in many regions of the world often forces people to travel long distances for an eye examination. This is often seen in low and middle-income countries. iHealthScreen’s AI-based tool can help in screening as well as prevention of late AMD.
Dr. Bhuiyan mentioned the study and findings that AI-based technology can diagnose the early stage of AMD which enables the appropriate preventative measures by an ophthalmologist as well as to prevent this deterioration of vision.
iHealthScreen is a private, clinical-stage medical diagnostic or device company. They have developed iPredict, an Artificial Intelligence and telemedicine-based HIPAA compliant platform for automated screening as well as prediction of individuals at risk of developing late Age-Related Macular Degeneration (AMD), glaucoma, cardiovascular heart disease, diabetic retinopathy (DR), and stroke.
